SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AB4. A total of 7 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 2.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $11,812,000 | -18.3% | 2,000,000 | -33.3% | 1.84% | +78.2% |
| Q4 2016 | $14,460,000 | +2.2% | 3,000,000 | 0.0% | 1.03% | -31.5% |
| Q3 2016 | $14,154,000 | +20.5% | 3,000,000 | 0.0% | 1.50% | -19.8% |
| Q2 2016 | $11,746,000 | +31.3% | 3,000,000 | 0.0% | 1.87% | +17.4% |
| Q1 2016 | $8,944,000 | -31.7% | 3,000,000 | -39.5% | 1.60% | -11.1% |
| Q4 2015 | $13,100,000 | -5.4% | 4,962,000 | 0.0% | 1.79% | -11.9% |
| Q3 2015 | $13,844,000 | -16.8% | 4,962,000 | 0.0% | 2.04% | -41.0% |
| Q2 2015 | $16,643,000 | +3.8% | 4,962,000 | -24.8% | 3.45% | -43.5% |
| Q1 2015 | $16,038,000 | +14.5% | 6,600,000 | -18.5% | 6.11% | -0.6% |
| Q4 2014 | $14,013,000 | – | 8,100,000 | – | 6.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|